Trajectories of Physical Function in Canadian Children With Juvenile Idiopathic Arthritis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patterns of Physical Function in Canadian Youth Diagnosed with Juvenile Idiopathic Arthritis

  • By

  • Clare Cunningham

  • Meghan McPherson

  • Lillian Lim

  • Roberta A. Berard

  • Matthew Berkowitz

  • Jean-Philippe Proulx-Gauthier

  • Brian M. Feldman

  • Nicole Johnson

  • Dax G. Rumsey

  • Heinrike Schmeling

  • Lori B. Tucker

  • Thomas Loughin

  • Kristin M. Houghton

  • Jaime Guzman

  • May 14, 2026

Share

Clinical Report: Patterns of Physical Function in Canadian Youth with JIA

Overview

This study examines the functional impairments in Canadian youth diagnosed with juvenile idiopathic arthritis (JIA). Most patients showed mild to moderate impairments at diagnosis.

Background

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, leading to pain and functional impairments that can affect daily activities and quality of life. Understanding the patterns of physical function in JIA is crucial.

Data Highlights

No numerical data available in the provided source material.

Key Findings

  • Most children with JIA had mild to moderate functional impairments at diagnosis.
  • Median time to optimal function was 36 weeks post-diagnosis.
  • Rheumatoid factor-positive polyarthritis had the largest functional impact, while psoriatic arthritis had the least.
  • 38% of patients were assigned to trajectories with persisting mild functional impairments.
  • 79% of patients with a baseline Kids Disability Screen ≥1.5 had persisting mild impairments.
  • 8% of patients reported moderate to severe impairment at least once beyond two years after diagnosis.

Clinical Implications

Early identification of children at risk for long-term functional impairments is essential.

Conclusion

The study provides insights into the functional impairments in children with JIA.

Related Resources & Content

  1. Trajectories of Physical Function in Canadian Children with Juvenile Idiopathic Arthritis - PubMed
  2. ACR Releases Updated Juvenile Idiopathic Arthritis Guidelines | American College of Rheumatology
  3. Arthritis Care & Research — Validation of the Pediatric Arthritis Ultrasound Scoring System for the Elbow, Wrist, and Finger Joints in Children With Juvenile Idiopathic Arthritis
  4. Clinical Rheumatology — Evaluating the Measurement Characteristics of the Juvenile Arthritis Functional Assessment Scale Against the Childhood Health Assessment Questionnaire in Clinical Settings
  5. European Radiology — Key Insights on Juvenile Idiopathic Arthritis for Radiologists: Recommendations from the European Society of Paediatric Radiology
  6. Clinical Rheumatology — Characterization of Polyunsaturated Fatty Acids in Juvenile Idiopathic Arthritis and Their Relationship with Disease Activity
  7. ACR Releases Updated Juvenile Idiopathic Arthritis Guidelines | American College of Rheumatology
  8. Trajectories of Physical Function in Canadian Children with Juvenile Idiopathic Arthritis - PubMed
  9. Effect of exercise interventions on physical function, cardiorespiratory fitness, and health-related quality of life in patients with juvenile idiopathic arthritis: a meta-analysis of randomized controlled trials | BMC Pediatrics | Springer Nature Link

Original Source(s)

Trajectories of Physical Function in Canadian Children With Juvenile Idiopathic Arthritis

  • by Clare Cunningham, Meghan McPherson, Lillian Lim, Roberta A. Berard, Matthew Berkowitz, Jean-Philippe Proulx-Gauthier, Brian M. Feldman, Nicole Johnson, Dax G. Rumsey, Heinrike Schmeling, Lori B. Tucker, Thomas Loughin, Kristin M. Houghton, Jaime Guzman

  • May 14, 2026

Related Content

Emergency in pediatric rheumatology: a narrative review

Did Medicine Lose Its Aura Before AI?

From the clinical gaze to electronic health records, a JAMA essay traces the long technological arc that set the stage for AI in medicine.

MMF Shows Promise in Juvenile Scleroderma

Mycophenolate mofetil demonstrated comparable disease control with fewer adverse effects.